EUVIMEDEUVIMED entdecken
Crossref

26-A-9768-ACC REAL-WORLD LIPID-LOWERING EFFICACY AND GOAL ATTAINMENT WITH ATORVASTATIN/EZETIMIBE FIXED-DOSE COMBINATION THERAPY

Byung Gyu Kim, Seong-Mi Park

JACC · 2026-04 · 87 (13) · A170-A171

DOI: 10.1016/j.jacc.2026.02.425 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JACC, 2026-04. Verfasst von Byung Gyu Kim und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Kim, B. G., & Park, S. (2026). 26-A-9768-ACC REAL-WORLD LIPID-LOWERING EFFICACY AND GOAL ATTAINMENT WITH ATORVASTATIN/EZETIMIBE FIXED-DOSE COMBINATION THERAPY. JACC, 87(13), A170-A171. https://doi.org/10.1016/j.jacc.2026.02.425

Vancouver

Kim BG, Park S. 26-A-9768-ACC REAL-WORLD LIPID-LOWERING EFFICACY AND GOAL ATTAINMENT WITH ATORVASTATIN/EZETIMIBE FIXED-DOSE COMBINATION THERAPY. JACC. 2026;87(13):A170-A171. doi:10.1016/j.jacc.2026.02.425

BibTeX
@article{Kim2026,
  author = {Kim, Byung Gyu and Park, Seong-Mi},
  title = {26-A-9768-ACC REAL-WORLD LIPID-LOWERING EFFICACY AND GOAL ATTAINMENT WITH ATORVASTATIN/EZETIMIBE FIXED-DOSE COMBINATION THERAPY},
  journal = {JACC},
  year = {2026},
  volume = {87},
  number = {13},
  pages = {A170--A171},
  doi = {10.1016/j.jacc.2026.02.425}
}
Kostenlos starten →